InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by member/Executive/Associated Person. Insider active across 3 companies, notably Novo Nordisk A/S. Cumulatively, 114 disclosures have been published. Activity tracked since 31 October 2016. The latest transaction was filed on 7 May 2026 (Gift). Regulator: Finanstilsynet DK. All data is accessible without signup.
Declarations114 total
●
50 shares@ DKK 294.2670.0% of flowShareOutside a trading venueDK:1441704
26,246 shares@ DKK 315.600.0% of flowShareJANE STREET NETHERLANDS B.V.DK:1419574
●
22,000 shares@ DKK 319.800.0% of flowShareNasdaq CopenhagenDK:1419156
1,085 shares0ShareOutside a trading venueDK:1418330
6,450 shares@ DKK 312.500.0% of flowShareNasdaq CopenhagenDK:1401014
Ideal exit: 14 Aug 2026 (T+270)
18,634 shares0ShareOutside a trading venueDK:1399962
952 shares@ DKK 349.060.0% of flowShareNew York Stock ExchangeDK:1384043
Ideal exit: 15 May 2026 (T+270)
12,000 shares@ DKK 326.000.0% of flowShareNasdaq CopenhagenDK:1382865
28,710 shares@ DKK 295.000.0% of flowShareNasdaq CopenhagenDK:1382513
74 shares@ DKK 316.750.0% of flowShareCGETDK:1382344
20,000 shares@ DKK 444.820.0% of flowShareNasdaq CopenhagenDK:1362269
40,000 shares@ DKK 620.260.1% of flowShareNasdaq CopenhagenDK:1341672
1,407 shares0ShareOutside a trading venueDK:1341302
2,500 shares@ DKK 709.250.0% of flowShareNew York Stock ExchangeDK:1328724
Ideal exit: 15 Aug 2025 (T+270)
1,300 shares@ DKK 743.310.0% of flowShareNew York Stock ExchangeDK:1327620
Ideal exit: 9 Aug 2025 (T+270)
18,634 shares0ShareOutside a trading venueDK:1327424
1,400 shares@ DKK 753.020.0% of flowShareNew York Stock ExchangeDK:1326827
Ideal exit: 3 Aug 2025 (T+270)
1,400 shares@ DKK 697.240.0% of flowShareNew York Stock ExchangeDK:1326582
Ideal exit: 3 Aug 2025 (T+270)
12.742 shares@ DKK 904.410.0% of flowShareNew York Stock ExchangeDK:1313875
Ideal exit: 25 May 2025 (T+270)
@ €122.3383ShareNew York Stock ExchangeDK:1311855
Ideal exit: 17 May 2025 (T+270)
8,480 shares@ DKK 895.500.0% of flowShareNasdaq CopenhagenDK:1310732
●
11 shares@ DKK 891.200.0% of flowShareNasdaq CopenhagenDK:1310299
Ideal exit: 6 May 2025 (T+270)
208.385 shares@ DKK 819.720.0% of flowShareNew York Stock ExchangeDK:1310156
Ideal exit: 4 May 2025 (T+270)
37 shares@ DKK 8.000.0% of flowShareNew York Stock ExchangeDK:1309977
Ideal exit: 5 May 2025 (T+270)
9,000 shares@ DKK 915.500.0% of flowShareNasdaq CopenhagenDK:1295786
25 of 114 declarations
About member/Executive/Associated Person
Member, Director at Novo Nordisk A/S.
